公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2022 | Distinct genetic landscapes and their clinical implications in younger and older patients with myelodysplastic syndromes | WAN-HSUAN LEE ; CHIEN-CHIN LIN ; Wang, Yu-Hung; CHI-YUAN YAO ; Kuo, Yuan-Yeh; Tseng, Mei-Hsuan; Peng, Yen-Ling; Hsu, Cheng-An; Sun, Hsun-I; Chuang, Yi-Kuang; Hsu, Chia-Lang; FENG-MING TIEN ; Tsai, Cheng-Hong; WEN-CHIEN CHOU ; HSIN-AN HOU ; HWEI-FANG TIEN | Hematological oncology | 0 | 0 | |
2022 | Distinct Immunogenetic Profiles of Chronic Lymphocytic Leukemia in Asia: A Taiwan Cooperative Oncology Group Registry Study | CHI-YUAN YAO ; Agathangelidis, Andreas; Chuang, Shih-Sung; Tsou, Hsiao-Hui; Feng, Wei-Lien; Liu, Ta-Chih; Chen, Tsai-Yun; Yu, Yuan-Bin; Yeh, Su-Peng; MING YAO ; Wang, Chuan-Cheng; Lin, Johnson; Hwang, Wen-Li; Gau, Jyh-Pyng; WEN-CHIEN CHOU ; Chao, Tsu-Yi; LIANG-IN LIN ; HWEI-FANG TIEN ; Ghia, Paolo; SHANG-JU WU | HemaSphere | 2 | 1 | |
2016 | Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS) | CHI-YUAN YAO ; HSIN-AN HOU ; Lin, Tzung-Yi; CHIEN-CHIN LIN ; WEN-CHIEN CHOU ; Tseng, Mei-Hsuan; Chiang, Ying-Chieh; Liu, Ming-Chih; Liu, Chia-Wen; Kuo, Yuan-Yeh; SHANG-JU WU ; Liao, Xiu-Wen; Lin, Chien-Ting; BOR-SHENG KO ; Chen, Chien-Yuan ; SZU-CHUN HSU ; Li, Chi-Cheng; SHANG-YI HUANG ; MING YAO ; JIH-LUH TANG ; WOEI TSAY ; Liu, Chieh-Yu; HWEI-FANG TIEN | Oncotarget | 19 | 18 | |
2012 | DNMT3A mutations in acute myeloid leukemia: Stability during disease evolution and clinical implications | HSIN-AN HOU ; Kuo Y.-Y.; Liu C.-Y.; WEN-CHIEN CHOU ; Lee M.C.; Chen, Chien-Yuan ; LIANG-IN LIN ; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Blood | 195 | 184 | |
2011 | Dynamic contrast-enhanced MR imaging measurement of vertebral bone marrow perfusion may be indicator of outcome of acute myeloid leukemia patients in remission | BANG-BIN CHEN ; CHAO-YU HSU ; CHIH-WEI YU ; HSIN-AN HOU ; Liu C.-Y.; Wei S.-Y.; WEN-CHIEN CHOU ; HWEI-FANG TIEN ; TIFFANY TING-FANG SHIH | Radiology | 40 | 29 | |
2018 | Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome | MING-EN LIN ; HSIN-AN HOU ; CHENG-HONG TSAI ; SHANG-JU WU ; Kuo Y.-Y.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; WEN-CHIEN CHOU ; Chen, Chien-Yuan ; JIH-LUH TANG ; MING YAO ; Li C.-C.; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; Lin C.-T.; HWEI-FANG TIEN | Clinical Epigenetics | 30 | 25 | |
2024 | Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations | FENG-MING TIEN ; CHI-YUAN YAO ; Tsai, Xavier Cheng-Hong; Lo, Min-Yen; Chen, Chien-Yuan; WAN-HSUAN LEE ; CHIEN-CHIN LIN ; Kuo, Yuan-Yeh; Peng, Yen-Ling; Tseng, Mei-Hsuan; Wu, Yu-Sin; Liu, Ming-Chih; LIANG-IN LIN ; MING-KAI CHUANG ; BOR-SHENG KO ; MING YAO ; Tang, Jih-Luh; WEN-CHIEN CHOU ; HSIN-AN HOU ; HWEI-FANG TIEN | Blood cancer journal | 0 | | |
2022 | Effect of mutation allele frequency on the risk stratification of myelodysplastic syndrome patients | WAN-HSUAN LEE ; CHIEN-CHIN LIN ; CHENG-HONG TSAI ; Tseng, Mei-Hsuan; YUAN-YEH KUO ; Liu, Ming-Chih; JIH-LUH TANG ; Sun, Hsun-I; Chuang, Yi-Kuang; WEN-CHIEN CHOU ; HSIN-AN HOU ; HWEI-FANG TIEN | American journal of hematology | 4 | 4 | |
2022 | Effectiveness of induction regimens on survival outcome in acute myeloid leukemia patients: a real-world data from 2001 to 2015 | HSIN-AN HOU ; Tzeng, Huey-En; Liu, Hung-Yi; WEN-CHIEN CHOU ; HWEI-FANG TIEN ; Chien, Li-Nien | Annals of hematology | 1 | 1 | |
2017 | Efficacy, safety, and pharmacokinetics of subcutaneous azacitidine in Taiwanese patients with higher-risk myelodysplastic syndromes | WEN-CHIEN CHOU ; Yeh S.-P.; Hsiao L.-T.; Lin S.-F.; Chen Y.-C.; Chen T.-Y.; Laille E.; Galettis A.; Dong Q.; Songer S.; Beach C.L. | Asia-Pacific Journal of Clinical Oncology | 6 | 4 | |
2019 | Emerging Mutations at Relapse in Patients with FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia Who Received Gilteritinib Therapy in the Phase 3 Admiral Trial | Smith C.C.; Levis M.J.; Perl A.E.; Martinelli G.; Neubauer A.; Berman E.; Montesinos P.; Baer M.R.; Larson R.A.; WEN-CHIEN CHOU ; Yokoyama H.; Recher C.; Yoon S.-S.; Hill J.E.; Rosales M.; Bahceci E. | Blood | 6 | 14 | |
2022 | Epidemiology and survival outcomes of acute myeloid leukemia patients in Taiwan: A national population-based analysis from 2001 to 2015 | Chien, Li-Nien; Tzeng, Huey-En; Liu, Hung-Yi; WEN-CHIEN CHOU ; HWEI-FANG TIEN ; HSIN-AN HOU | Journal of the Formosan Medical Association = Taiwan yi zhi | 6 | 2 | |
2007 | Erratum: A novel fluorescence-based multiplex PCR assay for rapid simultaneous detection of CEBPA mutations and NPM mutations in patients with acute myeloid leukemias (Leukemia (2007) vol. 21 (2236) 10.1038/sj.leu.2404888) | LIANG-IN LIN ; Lin T.-C.; WEN-CHIEN CHOU ; JIH-LUH TANG ; Lin D.-T.; HWEI-FANG TIEN | Leukemia | 1 | 2 | |
2023 | Evaluation of the clinical significance of global mRNA alternative splicing in patients with acute myeloid leukemia | YI-TSUNG YANG ; CHI-YUAN YAO ; PO-JU CHIU ; Kao, Chein-Jun; HSIN-AN HOU ; CHIEN-CHIN LIN ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | American journal of hematology | 1 | 1 | |
2021 | The expression levels of long non-coding RNA KIAA0125 are associated with distinct clinical and biological features in myelodysplastic syndromes | SHENG-YU HUNG ; CHIEN-CHIN LIN ; CHIA-LANG HSU ; CHI-YUAN YAO ; Wang, Yu-Hung; CHENG-HONG TSAI ; HSIN-AN HOU ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | British journal of haematology | 4 | 4 | |
2008 | Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia | HSIN-AN HOU ; WEN-CHIEN CHOU ; LIANG-IN LIN ; JIH-LUH TANG ; Tseng M.-H.; Huang C.-F.; MING YAO ; Chen, Chien-Yuan ; WOEI TSAY ; HWEI-FANG TIEN | Leukemia Research | 57 | 50 | |
2016 | Expression of CALR mutants causes mpl-dependent thrombocytosis in zebrafish | Lim K.-H.; Chang Y.-C.; Chiang Y.-H.; Lin H.-C.; Chang C.-Y.; Lin C.-S.; Huang, L.; Wang W.-T.; Chen, C. Gon-Shen; WEN-CHIEN CHOU ; YUAN-YEH KUO | Blood Cancer Journal | 21 | 19 | |
2014 | Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma | SHANG-YI HUANG ; CHUNG-WU LIN ; Lin H.-H.; MING YAO ; JIH-LUH TANG ; SHANG-JU WU ; YAO-CHANG CHEN ; Lu H.-Y.; HSIN-AN HOU ; Chen, Chien-Yuan ; WEN-CHIEN CHOU ; WOEI TSAY ; Chou S.-J.; HWEI-FANG TIEN | Annals of Hematology | 53 | 48 | |
2020 | False-positive Aspergillus galactomannan immunoassays associated with intravenous human immunoglobulin administration | WANG-DA LIU ; SHU-WEN LIN ; Shih, M. C.; Su, C. L.; Wang, Y. W.; Lin, S. C.; Lee, Y. F.; HUAI-HSUAN HUANG ; WEN-CHIEN CHOU ; UN-IN WU ; YEE-CHUN CHEN ; SHAN-CHWEN CHANG | Clinical Microbiology and Infection | 12 | 8 | |
2015 | Frequent CALR exon 9 alterations in JAK2 V617F-mutated essential thrombocythemia detected by high-resolution melting analysis | Lim K.-H.; Chang Y.-C.; Gon-Shen Chen C.; Lin H.-C.; Wang W.-T.; Chiang Y.-H.; Cheng H.-I.; Su N.-W.; Lin J.; Chang Y.-F.; Chang M.-C.; Hsieh R.-K.; Kuo Y.-Y.; WEN-CHIEN CHOU | Blood Cancer Journal | 23 | 25 | |